EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Automated and systematic screening of ion-pair reversed-phase LC conditions accelerating assay development of oligonucleotides in pharmaceutical mixtures

Jonathan Maurer, Mohamed Hemida, Rodell C Barrientos, Erik L Regalado, Davy Guillarme

Journal of Chromatography A · 2026

DOI: 10.1016/j.chroma.2026.467309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chromatography A, 2026. Verfasst von Jonathan Maurer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland; School of Pharmaceutical Sciences, University…. Hauptthemen laut MEDLINE: Chromatography, Reverse-Phase, Oligonucleotides. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pharmaceutical industry is rapidly advancing toward new drug modalities to address unmet medical needs, requiring the development of advanced analytical strategies for deployment of effective and reliable assays. Ion-pair reversed-phase liquid chromatography (IP-RPLC) is widely regarded as a reference technique for the analysis of therapeutic oligonucleotides; however, method development remains challenging because retention and selectivity are highly sensitive to the nature of the ion-pairing reagent, organic modifier, and stationary phase. Here, we present a high-throughput IP-RPLC screening platform to systematically evaluate these parameters for the separation of challenging oligonucleotide impurities. The setup combined three bioinert reversed-phase columns of different chemistries (i.e., BEH C18, BEH phenyl, and BEH C18 Shield) with multiple mobile phase compositions containing alkylamines of increasing hydrophobicity with either methanol or acetonitrile as organic modifier. Three representative commercially available oligonucleotide sample sets were investigated: shortmers and longmers from a synthetic antisense oligonucleotide, phosphodiester/phosphorothioate (PO/PS) oxidation variants related to 21-mer fomivirsen, and low-purity 18-mer synthetic ASO samples containing a broad range of process-related impurities. Separation quality was evaluated through the Separation Quality Factor (SQF). For shortmers/longmers separation, 20 mM butylamine with methanol on a phenyl column provided the best overall compromise in terms of resolution and number of detected oligonucleotide peaks, enabling baseline separation of five species in 95% to 30%. Overall, the proposed automated screening strategy enabled rapid identification of suitable IP-RPLC conditions for distinct oligonucleotide impurity classes and appears particularly well suited for accelerating method development for emerging therapeutic oligonucleotides.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chromatography, Reverse-PhaseOligonucleotidesPharmaceutical PreparationsHigh-Throughput Screening AssaysDrug Contamination

Stichwörter der Autor:innen

AlkylamineAutomated screeningImpurities profilingIon-pairing reversed-phase liquid chromatographyOligonucleotides

Substanzen

OligonucleotidesPharmaceutical Preparations

Autor:innen und Institutionen

  • Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
  • Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, NJ, 07065, United States.
  • Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland. Electronic address: davy.guillarme@un…

Zitieren

APA

Maurer, J., Hemida, M., Barrientos, R. C., Regalado, E. L., & Guillarme, D. (2026). Automated and systematic screening of ion-pair reversed-phase LC conditions accelerating assay development of oligonucleotides in pharmaceutical mixtures. Journal of Chromatography A. https://doi.org/10.1016/j.chroma.2026.467309

Vancouver

Maurer J, Hemida M, Barrientos RC, Regalado EL, Guillarme D. Automated and systematic screening of ion-pair reversed-phase LC conditions accelerating assay development of oligonucleotides in pharmaceutical mixtures. Journal of Chromatography A. 2026. doi:10.1016/j.chroma.2026.467309

BibTeX
@article{Maurer2026,
  author = {Maurer, Jonathan and Hemida, Mohamed and Barrientos, Rodell C and Regalado, Erik L and Guillarme, Davy},
  title = {Automated and systematic screening of ion-pair reversed-phase LC conditions accelerating assay development of oligonucleotides in pharmaceutical mixtures},
  journal = {Journal of Chromatography A},
  year = {2026},
  doi = {10.1016/j.chroma.2026.467309}
}
Kostenlos starten →